News & Press
BIOTRONIK Neuro acquires Soin Neuroscience’s SCS IP portfolio
www.medicaldevice-network.com7/16/2026·07/16/26🌐 Europe
Summary
BIOTRONIK Neuro acquired a portfolio of intellectual property from Soin Neuroscience covering spinal cord stimulation waveform design, adaptive programming and machine-learning integration. The assets will support development of next-generation SCS systems for chronic pain while Soin remains an independent company.
Why it matters
BIOTRONIK's acquisition of Soin Neuroscience's SCS intellectual property consolidates spinal cord stimulation patents under an established neurostimulation manufacturer, extending its competitive position in chronic pain therapy.
#SCS#Neuromodulation#Acquisition#Pain Management#AI/ML
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in